StockData
Coherent Corp. logo

Coherent Corp. (COHR) stock analysis

COHRNYSEOptical Instruments & LensesFiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 13/3015% above fair value
$232.08−2.43 (-1.04%)

Close on Nov 12, 2026Market cap $45.45BP/E 48.1Yield –

StockData Score

Prices as of Nov 11, 2026How the score works

Value1Growth4Performance4Health4Dividend0

Mixed13 of 30 checks passed

Coherent passes 13 of the 30 checks behind our score; 10 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.

Valuation
1/6
Growth
4/6
Past performance
4/6
Financial health
4/6
Dividend
0/6

What stands out

  • Low debt

    Debt is 35.3% of shareholders' equity, under the 40% we consider low.

  • Earnings grew over 5 years

    Net income grew 22.0% a year on average over the last five fiscal years.

  • Revenue growing 10%+ a year

    Revenue grew 11.3% a year over the last three fiscal years.

  • Earnings growth accelerating

    Net income grew 286% over the last twelve months, against a 5-year average of 22.0% a year.

What to watch

  • Margin of safety under 20%

    The price is 15.0% above fair value, so there is no margin of safety.

  • Trading above fair value

    The share price of $234.51 is above our fair value estimate of $203.84.

  • Return on equity under 15%

    Return on equity was 11.2% over the last twelve months and averaged 1.6% over five years; we look for 15% on both.

  • Debt not well covered by cash flow

    Operating cash flow over the last twelve months equals -1.5% of total debt; we look for at least 20%.

Valuation1/6
  • P/E below its 5-year median

    Coherent's P/E of 48.7 is below its own 5-year median of 68.4.

  • P/E above the industry

    Coherent's P/E of 48.7 is above the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median of 36.5.

  • EV/EBITDA against its history

    Needs positive EBITDA and price history.

  • P/B above the industry

    Coherent's price-to-book of 4.05 is above the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median of 3.17.

  • Trading above fair value

    The share price of $234.51 is above our fair value estimate of $203.84.

  • Margin of safety under 20%

    The price is 15.0% above fair value, so there is no margin of safety.

Growth4/6
  • Revenue growing 10%+ a year

    Revenue grew 11.3% a year over the last three fiscal years.

  • EPS growth over 3 years

    Needs positive EPS three years ago and today.

  • Earnings growth accelerating

    Net income grew 286% over the last twelve months, against a 5-year average of 22.0% a year.

  • Growing faster than the industry

    Revenue grew 30.8% over the last twelve months; the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median is 8.4%.

  • Guidance issued

    The latest outlook (first quarter of fiscal 2027 Revenue, Aug 12, 2026) was issued for the first time, so it neither adds nor takes away points.

  • Gross margin improving

    Gross margin was 38.2% over the last twelve months, against 35.8% a year earlier.

Past performance4/6
  • Return on equity under 15%

    Return on equity was 11.2% over the last twelve months and averaged 1.6% over five years; we look for 15% on both.

  • Return on invested capital

    Needs operating income and invested capital.

  • Return on equity above the industry

    Coherent's return on equity of 11.2% is above the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median of 1.1%.

  • Earnings grew over 5 years

    Net income grew 22.0% a year on average over the last five fiscal years.

  • Net margin above its 5-year average

    Net margin was 12.2% over the last twelve months, against a 5-year average of 2.2%.

  • Net margin above the industry

    Coherent's net margin of 12.2% is above the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median of -1.3%.

Financial health4/6
  • Low debt

    Debt is 35.3% of shareholders' equity, under the 40% we consider low.

  • Debt falling against equity

    Debt to equity fell from 40.4% five years ago to 35.3%.

  • Debt not well covered by cash flow

    Operating cash flow over the last twelve months equals -1.5% of total debt; we look for at least 20%.

  • Interest coverage

    Interest expense is not reported separately.

  • Short-term assets cover short-term debts

    Current assets are 2.29 times current liabilities.

  • Low bankruptcy risk

    The Altman Z-score is 3.98; above 3 is the safe zone and below 1.8 the distress zone.

Dividend0/6
  • No dividend

    Coherent has not paid a dividend in the last twelve months.

  • Yield against Treasuries

    No dividend.

  • Yield against the market

    No dividend.

  • Dividend stability

    No dividend.

  • Earnings cover

    No dividend.

  • Cash-flow cover

    No dividend.

Scores of similar companies

Our estimate per share

$203.84

The share price is 15% above this estimate.

20%+ below
Near fair value
20%+ above
$234.51Price$203.84Fair value
MethodMultiple usedOwn 5Y medianIndustry medianValue per shareWeight
P/E45.0×68.4×36.5×$216.9080%
P/B2.6×2.1×3.2×$151.6120%
Fair value$203.84100%

Valuation over time

Using the earnings and balance sheet published at each date, not today's.

  • P/E at month end
  • Own 5-year median 68.4
  • Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median 36.5

An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.

Market risk

From the past year of daily prices.

Liquidity

Low risk

Average value traded per day
$2.17B
Value traded per 1% price move
$455.59M

Downside

High risk

Typical loss in a bad month
37.6%
Volatility (annualized)
91%
Sharpe ratio, 1 year
0.40
Beta to the S&P 500 (5Y)
2.34

Typical bad-month loss, week by week

25%: high

Margins

Share of revenue, fiscal years 2012 to 2026

Gross margin

37.5%−0.4 pts over 5 years

Operating margin

–

Net margin

11.3%+1.7 pts over 5 years

See a number that looks wrong?